Regulatory Approval, Reimbursement, and Clinical Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Metastatic Breast Cancer in the Netherlands

Marianne Luyendijk*, Hedwig Blommestein, Carin Uyl-De Groot, Sabine Siesling, Agnes Jager

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

7 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Regulatory Approval, Reimbursement, and Clinical Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Metastatic Breast Cancer in the Netherlands'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry